| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.062 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |